Article Sidebar
Published:
Aug 28, 2013DOI:
10.4314/tjpr.v12i4.3Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Formulation and In vitro Evaluation of Carvedilol Transdermal Delivery System
Abstract
Purpose: To develop and optimize carvedilol transdermal delivery system.
Methods: Solvent casting method was used to prepare patches using polymethyl methacrylate (PMMA) and Eudragit E100 (EE100) polymers, dimethylsulfoxide (DMSO) penetration enhancer, dibutylphthalate (DBP) plasticizer and Tween 80 surfactant. A 23 factorial design was used based on three variables (PMMA, EE100, DMSO). at two levels Second order polynomial equations indicating interplay of ingredients were obtained by factorial design using SigmaTech software for 1, 4, 8 and 20 h release data. so the design was extended to central composite design (CCD). The target formulation was obtained from contour plots and evaluated for various physicochemical parameters. including in-vitro dissolution studies.
Results: Curvature effect was observed in F1 to F8 formulations, highlighting the interplay of ingredients. The interaction term (X2X3)exhibited highest Sum of Squares SS ratio at 1, 4, and 8 h data with positive coefficients indicating interaction; and so extended to CCD. From contour plots target formulation, F19, was identified and evaluated. The release data, were subjected to kinetic analysis, which followed Higuchi (diffusion) model (R2 = 0.9886).
Conclusion: F19 yielded release profile nearer to the theoretical predictions with R2 of 0.9888 and followed Higuchi kinetics. Thus, a diffusion-mediated carvedilol matrix patch was successfully developed.
Keywords: Carvedilol, Central composite design, Drug release, Transdermal patch.
